PHM4 UK COST COMPARISON OF BUCY2 CONDITIONING IN ALLOGENEIC HSCT- ORAL VERSUS IV BUSULFAN (BUSILVEX®)
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67534-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)67534-1/fulltext
Section Title :
Section Order :
103
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67534-1&doi=10.1016/S1098-3015(10)67534-1